KILL New Long-Term Data for Genentech’s Vabysmo Show Sustained Retinal Drying and Vision Improvements in Retinal Vein Occlusion (RVO)

 

Genentech requests that their press release NewsItemId: 20240125093104 “New Long-Term Data for Genentech’s Vabysmo Show Sustained Retinal Drying and Vision Improvements in Retinal Vein Occlusion (RVO)” be killed.

The release was issued prematurely by Genentech.

A replacement release will be issued at a later date.

Contacts

Media Contact:

Shirley Dang, (650) 467-6800

Advocacy Contact:

Danielle Haney, (240) 805-4810

Investor Contacts:

Loren Kalm, (650) 225-3217

Bruno Eschli, +41 61 687 5284

Recent Quotes

View More
Symbol Price Change (%)
AMZN  226.52
+0.24 (0.11%)
AAPL  278.06
+2.14 (0.77%)
AMD  196.72
-18.33 (-8.52%)
BAC  52.37
+0.44 (0.85%)
GOOG  324.81
+6.34 (1.99%)
META  624.39
+11.35 (1.85%)
MSFT  466.81
-7.19 (-1.52%)
NVDA  170.79
-11.76 (-6.44%)
ORCL  190.07
-10.21 (-5.10%)
TSLA  409.25
-8.53 (-2.04%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.